Chardan Capital Increases Lexeo Therapeutics (NASDAQ:LXEO) Price Target to $25.00
Lexeo Therapeutics (NASDAQ:LXEO – Get Free Report) had its price objective increased by equities researchers at Chardan Capital from $23.00 to $25.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Chardan Capital’s target price indicates a potential upside of 227.23% from […]
More Stories
Uber Technologies (NYSE:UBER) Trading 1.4% Higher – Time to Buy?
Shares of Uber Technologies, Inc. (NYSE:UBER – Get Free Report) were up 1.4% during mid-day trading on Thursday . The...
Lam Research (NASDAQ:LRCX) Stock Price Up 1.9% – Here’s What Happened
Shares of Lam Research Co. (NASDAQ:LRCX – Get Free Report) shot up 1.9% during trading on Thursday . The stock...
MARA (NASDAQ:MARA) Trading Down 5.4% – What’s Next?
MARA Holdings, Inc. (NASDAQ:MARA – Get Free Report) shares dropped 5.4% on Thursday . The stock traded as low as...
Coinbase Global (NASDAQ:COIN) Trading Down 2.1% – Here’s What Happened
Coinbase Global, Inc. (NASDAQ:COIN)’s share price dropped 2.1% during trading on Thursday . The stock traded as low as $276.89...
BrightSpring Health Services, Inc. (NASDAQ:BTSGU) Short Interest Update
BrightSpring Health Services, Inc. (NASDAQ:BTSGU – Get Free Report) was the recipient of a significant increase in short interest during...
Tesla, Inc. (NASDAQ:TSLA) Shares Bought by Omnia Family Wealth LLC
Omnia Family Wealth LLC increased its holdings in Tesla, Inc. (NASDAQ:TSLA – Free Report) by 20.6% during the 3rd quarter,...